SBBP Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 jan 1970 @ 01:00):

Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs...

Stats
Dagens volum	684 683
Gjennomsnittsvolum	316 352
Markedsverdi	0.00
EPS	$-0.0700 ( 2021-08-05 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.111 (5.55%)

Insider Trading

Date	Person	Action	Amount	type
2021-10-05	Cdk Associates, L.l.c.	Sell	8 060 682	Ordinary Shares, $0.01 par value
2021-10-05	Cdk Associates, L.l.c.	Sell	2 220 000	Ordinary Shares Warrant (right to buy)
2021-10-05	Wilhoit Scott L.	Sell	109 510	Ordinary Shares
2021-10-05	Wilhoit Scott L.	Sell	649 000	Stock Option (Right to Buy)
2021-10-05	Kollender Richard S	Sell	234 229	Ordinary Shares

INSIDER POWER
0.00
Last 99 transactions
Buy: 6 188 774 \| Sell: 17 044 650

Volum Korrelasjon

Lang: 0.22 (neutral)

Kort: -0.76 (moderate negative)

Signal:(42.06) Neutral

Strongbridge Biopharma Korrelasjon

10 Mest positive korrelasjoner
ATNX	0.904
FINW	0.898
ORRF	0.896
RAPT	0.895
CFV	0.894
REKR	0.891
COMM	0.89
VIEW	0.889
GMII	0.889
SABR	0.888

10 Mest negative korrelasjoner
DFH	-0.93
COUP	-0.912
ICON	-0.91
PCTI	-0.903
CRVL	-0.902
FEYE	-0.9
CVT	-0.899
TWNK	-0.894
CFMS	-0.891
BTF	-0.889

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Strongbridge Biopharma Korrelasjon - Valuta/Råvare

-0.12
( neutral )

-0.60
( weak negative )

0.00
( neutral )

0.01
( neutral )

0.38
( neutral )

0.81
( strong )

Strongbridge Biopharma Økonomi

Annual	2020
Omsetning:	$30.73M
Bruttogevinst:	$28.52M (92.80 %)
EPS:	$-0.780

FY	2020
Omsetning:	$30.73M
Bruttogevinst:	$28.52M (92.80 %)
EPS:	$-0.780

FY	2019
Omsetning:	$21.71M
Bruttogevinst:	$17.89M (82.40 %)
EPS:	$-0.910

FY	2018
Omsetning:	$18.03M
Bruttogevinst:	$14.04M (77.89 %)
EPS:	$0.690

Financial Reports:

No articles found.

Strongbridge Biopharma

Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs. The company offers Keveyis, an oral carbonic anhydrase inhibitor for treating hyperkalemic, hypokalemic, and related variants of primary periodic paralysis in the United States. Its clinical-stage product candidates include Recorlev, a cortisol synthesis inhibitor, which is in a Phase III clinical trials that for the treatment of endogenous Cushing's syndrome; and Veldoreotide, a somatostatin analog that completed Phase II clinical trial for the treatment of acromegaly. The company was formerly known as Cortendo plc and changed its name to Strongbridge Biopharma plc in September 2015. Strongbridge Biopharma plc was founded in 1996 and is headquartered in Trevose, Pennsylvania.